Factor Xa inhibitors: critical considerations for clinical development and testing
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-021-02455-x
Abstract: The selection of factor (F) X and its activated protease FXa for targeted inhibition to prevent and treat thrombotic conditions is based on an understanding of coagulation biochemistry, sequential steps that occur on tissue factor… read more here.
Keywords: factor inhibitors; critical considerations; inhibitors critical; considerations clinical ... See more keywords